Article

Good News for Coffee Lovers

Author(s):

Always a brewing topic, coffee drinking has been linked to a lower risk of dying from heart disease.

Always a brewing topic, coffee drinking has been linked to a lower risk of dying from heart disease.

Ming Ding, MD, Harvard School of Public Health, lead author and team explored the correlation between consumption of total, caffeinated, and decaffeinated coffee and risk of mortality.

The study, published in the journal Circulation, included a cohort of more than 200,000 doctors and nurses for up to 30 years. The participants were administered periodic physical examinations and required to complete questionnaires on diet and behavior, including their coffee habits.

The team controlled for age, alcohol consumption, BMI, and other health and diet factors.

According to the results, when compared with abstainers, nonsmokers who drank a cup of coffee a day had a 6% reduced risk of death; one to three cups a day, an 8% reduced risk; three to five cups a day, a 15% reduced risk; and more than 5 cups a day, a 12% reduced risk.

Additionally, coffee drinking was associated with a reduced risk of death from heart disease, stroke, diabetes, neurological diseases, and suicide, although not from cancer.

Furthermore, there was no link found in smokers, primarily since death from smoking-related causes overshadows the positive effect of coffee drinking.

Despite encouraging results, Ming emphasized, “Our study is observational, so it’s hard to know if the positive effect is causal or not.”

Related Videos
Experts' Perspectives: Top Stories in Cardiology for 2024
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orly Vardeny, PharmD: Finerenone for Heart Failure with EF >40% in FINEARTS-HF | Image Credit: JACC Journals
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Matthew Weir, MD: Prioritizing Cardiovascular Risk in Chronic Kidney Disease | Image Credit: University of Maryland
© 2024 MJH Life Sciences

All rights reserved.